Case C-567/16, Merck Sharp – SPC Lazarus law [judgment 2017, ECLI:EU:C:2017:948]
By judgment of 7 December 2017 (ECLI:EU:C:2017:948) the Court ruled, in the words of the operative part: “1.
Tag
pharma
26 case reports
Case C-329/16, SNITEM – against state diktats for healthcare software [judgment 2017, ECLI:EU:C:2017:947]
By judgment of 7 December 2017 (ECLI:EU:C:2017:947) the Court ruled, in the words of the operative part: “Article 1(1) and Article 1(2)(a) of Council Directive 93/42/EEC of 14 June 1993 concerning medical devices, as amended by Directive 2007/47/EC of the…
Case C-179/16, Hoffmann-La Roche – is off-label medicine use, off-limits to EU cartel law? [judgment 2018, ECLI:EU:C:2018:25]
By judgment of 23 January 2018 (ECLI:EU:C:2018:25) the Court ruled, in the words of the operative part: “1.
Case C-612/15, W and heirs – seeking to prove a defective vaccine [judgment 2018, ECLI:EU:C:2018:392]
By judgment of 5 June 2018 (ECLI:EU:C:2018:392) the Court ruled, in the words of the operative part: “1.
Case C-445/15, Nutricia – is an Alzheimer dairy product, a food for a special medical purpose?
A company has made a dairy product for patients with early onset Alzheimer’s Disease. The company believes that this makes it a ‘food for a special medical purpose’ within the EU Commission’s Directive 1999/21/EC. However, in the United Kingdom, the Secretary of State for Health believes that that…
Case C-282/15, Queisser Pharma – an amino acid is not necessarily mean to human health [judgment 2017, ECLI:EU:C:2017:26]
By judgment of 19 January 2017 (ECLI:EU:C:2017:26) the Court ruled, in the words of the operative part: “Articles 6 and 7 of Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general principles and…
Case C-276/15, Hecht-Pharma – incensed at the competition in Frankincense-extract capsules [judgment 2016, ECLI:EU:C:2016:801]
By judgment of 26 October 2016 (ECLI:EU:C:2016:801) the Court held that a product whose essential manufacturing steps are carried out in a pharmacy as part of its normal business, producing up to 100 dispensing-ready packages a day, is not prepared…
Case C-277/15, Servoprax – challenging language obstacles to parallel imported medical products [judgment 2016, ECLI:EU:C:2016:770]
By judgment of 13 October 2016 (ECLI:EU:C:2016:770) the Court ruled, in the words of the operative part: “Article 9 of Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices must be…
Case C-297/15, Ferring Lægemidler – artificially segmenting the market in laxatives? [judgment 2016, ECLI:EU:C:2016:857]
By judgment of 10 November 2016 (ECLI:EU:C:2016:857) the Court ruled, in the words of the operative part: “Article 7(2) of Directive 2008/95/EC of the European Parliament and of the Council of 22 October 2008 to approximate the laws of the Member States…
Case C-114/15, AUDACE – audacious French farmers buy Spanish veterinary medicinal products [judgment 2016, ECLI:EU:C:2016:813]
By judgment of 27 October 2016 (ECLI:EU:C:2016:813) the Court held that Articles 34 and 36 TFEU preclude national rules reserving parallel imports of veterinary medicinal products to authorised wholesalers, thereby excluding farmers who import for their…
Case C-148/15, Deutsche Parkinson Vereinigung – bonuses for buying Dutch mail order medicines [judgment 2016, ECLI:EU:C:2016:776]
By judgment of 19 October 2016 (ECLI:EU:C:2016:776) the Court held that Germany's system of fixed prices for prescription-only medicines, as applied to mail-order pharmacies established in other Member States, is a measure having equivalent effect contrary…
Case C-19/15, Verband Sozialer Wettbewerb – stopping a company making health claims to doctors [judgment 2016, ECLI:EU:C:2016:563]
By judgment of 14 July 2016 (ECLI:EU:C:2016:563) the Court ruled, in the words of the operative part: “Article 1(2) of Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on…
Case C-452/14, Doc Generici – one change to 62 marketing authorisations [judgment 2015, ECLI:EU:C:2015:644]
By judgment of 1 October 2015 (ECLI:EU:C:2015:644) the Court ruled, in the words of the operative part: “1.
Case C-442/14, Bayer CropScience – Bee deaths? Buzz Off! The data requested is confidential [judgment 2016, ECLI:EU:C:2016:890]
By judgment of 23 November 2016 (ECLI:EU:C:2016:890) the Court ruled, in the words of the operative part: “1.
Case C-410/14, Falk Pharma – objecting to a contract supplying a public body reduced-price medicine [judgment 2016, ECLI:EU:C:2016:399]
By judgment of 2 June 2016 (ECLI:EU:C:2016:399) the Court ruled, in the words of the operative part: “1.
Case C-379/14, TOP Logistics – from lex mercatoria to lex markatoria? [judgment 2015, ECLI:EU:C:2015:497]
By judgment of 16 July 2015 (ECLI:EU:C:2015:497) the Court ruled, in the words of the operative part: “Article 5 of the First Council Directive 89/104/EEC of 21 December 1988 to approximate the laws of the Member States relating to trade marks must be…
Case C-157/14, Neptune – mineral water salinity [judgment 2015, ECLI:EU:C:2015:823]
By judgment of 17 December 2015 (ECLI:EU:C:2015:823) the Court ruled, in the words of the operative part: “1.
Case C-568/13, Data Medical Service – objecting to public bodies tendering for procurement contracts [judgment 2014, ECLI:EU:C:2014:2466]
By judgment of 18 December 2014 (ECLI:EU:C:2014:2466) the Court ruled, in the words of the operative part: “1.
Case C-539/13, Merck Canada – prior notification under the Specific Agreement [judgment 2015, ECLI:EU:C:2015:87]
By judgment of 12 February 2015 (ECLI:EU:C:2015:87) the Court ruled, in the words of the operative part: “1.
Case C-358/13, D. – legal highs [judgment 2014, ECLI:EU:C:2014:2060]
By judgment of 10 July 2014 (ECLI:EU:C:2014:2060) the Court ruled, in the words of the operative part: “Article 1(2)(b) of Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal…
Case C-613/12, Helm Düngemittel – certifying the origin of a cargo from Egypt [judgment 2014, ECLI:EU:C:2014:52]
By judgment of 6 February 2014 (ECLI:EU:C:2014:52) the Court ruled, in the words of the operative part: “The Euro-Mediterranean Agreement establishing an association between the European Communities and their Member States, of the one part, and the Arab…
Case C-512/12, Octapharma France – on the regulation of plasma intended for transfusion [judgment 2014, ECLI:EU:C:2014:149]
By judgment of 13 March 2014 (ECLI:EU:C:2014:149) the Court ruled, in the words of the operative part: “1.
Case C-497/12, Gullotta – excluding some medicines from Italian para-pharmacies [judgment 2015, ECLI:EU:C:2015:436]
By judgment of 2 July 2015 (ECLI:EU:C:2015:436) the Court ruled, in the words of the operative part: “The questions referred by the Tribunale amministrativo regionale per la Sicilia (Italy), by decision of 9 October 2012, and maintained by that court, are…
Case C-299/12, Green-Swan Pharmaceuticals – a forbidden health claim benefiting from a transitional exception? [judgment 2013, ECLI:EU:C:2013:501]
By judgment of 18 July 2013 (ECLI:EU:C:2013:501) the Court ruled, in the words of the operative part: “1.
Case C-109/12, Lyocentre – when a medical device becomes a medicinal product [judgment 2013, ECLI:EU:C:2013:626]
By judgment of 3 October 2013 (ECLI:EU:C:2013:626) the Court ruled, in the words of the operative part: “1.
Case C-159/12, Venturini – excluding some pharma products from para-pharmacies [judgment 2013, ECLI:EU:C:2013:791]
By judgment of 5 December 2013 (ECLI:EU:C:2013:791) the Court ruled, in the words of the operative part: “Article 49 TFEU must be interpreted as not precluding national legislation, such as that at issue in the main proceedings, which does not allow a…